Phibro Animal Health (NASDAQ:PAHC) Trading Up 5.2% - What's Next?

Key Points

• Phibro Animal Health shares rose 5.2% to about $38.24 in Friday’s trading, although volume was 93% below the average session volume.
• Analyst sentiment remains cautious: the stock carries an average “Hold” rating with a $42.50 price target after several recent downgrades.
• The company beat quarterly earnings and revenue estimates, reporting $0.85 in EPS and $396.75 million in revenue, while declaring a quarterly dividend of $0.12 per share for a 1.3% annualized yield.

Phibro Animal Health Corporation (NASDAQ:PAHC - Get Free Report)'s stock price shot up 5.2% during mid-day trading on Friday . The company traded as high as $38.38 and last traded at $38.24. Approximately 21,217 shares were traded during trading, a decline of 93% from the average session volume of 294,857 shares. The stock had previously closed at $36.35.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on PAHC shares. Weiss Ratings cut shares of Phibro Animal Health from a "buy (b-)" rating to a "hold (c+)" rating in a report on Monday, June 15th. Zacks Research downgraded Phibro Animal Health from a "strong-buy" rating to a "hold" rating in a report on Thursday, May 21st. Citigroup decreased their price target on Phibro Animal Health from $62.00 to $44.00 and set a "neutral" rating for the company in a research note on Thursday, May 14th. Finally, Wall Street Zen lowered Phibro Animal Health from a "strong-buy" rating to a "buy" rating in a research note on Saturday, May 9th. One research analyst has rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, Phibro Animal Health currently has an average rating of "Hold" and an average price target of $42.50.

Phibro Animal Health Stock Performance

The company has a quick ratio of 1.26, a current ratio of 3.17 and a debt-to-equity ratio of 1.97. The stock has a market cap of $1.54 billion, a PE ratio of 15.58, a P/E/G ratio of 0.51 and a beta of 0.46. The stock has a 50-day moving average of $34.04 and a 200 day moving average of $42.32.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last issued its earnings results on Wednesday, August 26th. The company reported $0.85 EPS for the quarter, topping the consensus estimate of $0.71 by $0.14. Phibro Animal Health had a net margin of 6.57% and a return on equity of 39.28%. The company had revenue of $396.75 million for the quarter, compared to analyst estimates of $381.18 million. Phibro Animal Health has set its FY 2027 guidance at 3.410-3.590 EPS. Equities analysts predict that Phibro Animal Health Corporation will post 3.33 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Wednesday, September 2nd will be given a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 1.3%. The ex-dividend date of this dividend is Wednesday, September 2nd. Phibro Animal Health's dividend payout ratio is presently 20.60%.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. 1620 Investment Advisors Inc. lifted its position in shares of Phibro Animal Health by 77.4% in the 4th quarter. 1620 Investment Advisors Inc. now owns 676 shares of the company's stock worth $25,000 after acquiring an additional 295 shares during the period. Farther Finance Advisors LLC raised its stake in shares of Phibro Animal Health by 113.2% in the fourth quarter. Farther Finance Advisors LLC now owns 727 shares of the company's stock valued at $27,000 after purchasing an additional 386 shares in the last quarter. KBC Group NV bought a new position in Phibro Animal Health in the first quarter worth $29,000. Rothschild Investment LLC lifted its position in Phibro Animal Health by 2,500.0% in the fourth quarter. Rothschild Investment LLC now owns 1,040 shares of the company's stock worth $39,000 after purchasing an additional 1,000 shares during the period. Finally, iSAM Funds UK Ltd acquired a new stake in Phibro Animal Health during the third quarter worth $61,000. Institutional investors and hedge funds own 99.34% of the company's stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation NASDAQ: PAHC is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro's portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source